Search results
Acadia's Rett syndrome drug under priority review in Canada By Investing.com
Investing.com· 5 days agoAcadia Pharmaceuticals Inc. (NASDAQ:ACAD) has announced that its New Drug Submission for...
Ayala: San Antonio ‘it’ couple tells story of special needs child
San Antonio Express-News· 1 day agoIt’s been a huge week for Cruz and Olivia Ortiz. For the last three nights, they’ve reigned over “Cornyation 2024: The Court of Peripheral Opulence" as King Anchovy and his majesty’s “Snatched ...
Authorities Identify 3 Killed In Fiery Route 1 Crash In South Brunswick
Daily Voice· 5 days agoAuthorities have identified the three people killed in a fiery crash on Route 1 in South Brunswick...
Spanberger endorses Leslie Mehta in 1st District congressional race
Richmond Times-Dispatch· 10 hours agoMehta, 46, a former civil rights attorney in Chesterfield County, is running against New Kent County...
Neurogene Inc. (NASDAQ:NGNE) Forecasted to Post Q1 2024 Earnings of ($1.38) Per Share
ETF DAILY NEWS· 7 days agoNeurogene Inc. (NASDAQ:NGNE – Free Report) – William Blair dropped their Q1 2024 earnings estimates for Neurogene in a research note issued to investors on Wednesday, April 17th. William Blair ...
ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds...
Morningstar· 6 days agoNEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ: AVXL)?Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive?Did you lose
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp....
Benzinga· 2 days agoNEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 19 hours agoRobbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who purchased or otherwise acquired Anavex Life Sciences Corporation (NASDAQ: AVXL) stock between ...
AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences...
Morningstar· 3 days agoSAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Anavex Life Sciences Corporation (NASDAQ: AVXL) stock between February 1, 2022 and January 1, 2024, inclusive (the “Class Period
Cantor Fitzgerald Reaffirms “Overweight” Rating for Taysha Gene Therapies (NASDAQ:TSHA)
ETF DAILY NEWS· 7 days agoCantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report released on Thursday, Benzinga reports. They currently have a $7.00 ...